問卷
此案目前為暫存狀態
編修至YYYY/MM/DD
不開放編輯功能
Find Division/Department
Tri-Service General Hospital
All Location
All Division/Department
篩選
Developmental Phase
Phase I
Phase I/II
Phase II
Phase II/III
Phase III
Phase IV
Others
Trial Status
Not yet recruiting
Active
Completed
Recruitment Status
Recruiting
Terminated
Stop recruiting
Suspended
Study ended
Trial scale
Multi-Regional Multi-Center
Taiwan Multiple Center
Taiwan Single Center
The expected start time interval of the test
Trial Applicant
Hospital/Foundation
Pharmaceutical/Biopharmaceutical company
Contract Research Organization
Important Roles
Asia Regional PI
Taiwan National PI
Chairman/Global PI
Steering Committee
Advisory board
None
Audit by Sponsors/CRO
Sponsors
CRO
Investigator-initiated trial(IIT)
Yes
Filters
下載
2010-11-01 - 2018-06-30
Condition/Disease
Test Drug
Participate Sites5Sites
Terminated5Sites
2008-02-01 - 2010-12-31
Participate Sites3Sites
Terminated3Sites
2007-09-17 - 2012-05-31
Participate Sites8Sites
Terminated8Sites
2007-08-08 - 2008-08-31
2007-05-01 - 2008-12-01
Participate Sites6Sites
Terminated6Sites
2007-04-15 - 2008-09-30
Participate Sites1Sites
Terminated1Sites
2022-03-02 - 2023-11-10
Not yet recruiting1Sites
Recruiting2Sites
2022-01-01 - 2023-11-22
Primary Sjogren's Syndrome
Nipocalimab Solution for Intravenous Infusion
Participate Sites2Sites
2023-04-19 - 2024-03-21
Recruiting3Sites
2018-08-31 - 2026-05-31
Triple-Negative Breast Cancer
Atezolizumab (RO5541267)
Participate Sites13Sites
Not yet recruiting3Sites
Recruiting1Sites
Terminated9Sites
Division of General Surgery
全部
